Stockscreener 앱 받기
6.57
1.79%
-0.12
전일 마감가:
$6.69
열려 있는:
$6.7
하루 거래량:
2.92M
Relative Volume:
0.70
시가총액:
$1.07B
수익:
$1.08B
순이익/손실:
$422.82M
주가수익비율:
2.8816
EPS:
2.28
순현금흐름:
$-637.33M
1주 성능:
-4.92%
1개월 성능:
-8.75%
6개월 성능:
-8.11%
1년 성능:
-27.16%
1일 변동 폭
$6.4301
$6.71
1주일 범위
$6.4301
$7.035
52주 변동 폭
$5.01
$11.55
노바백스 Stock (NVAX) Company Profile
명칭
Novavax Inc
전화
240-268-2000
주소
700 QUINCE ORCHARD ROAD, GAITHERSBURG, MD
NVAX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NVAX
Novavax Inc
|
6.57 | 1.09B | 1.08B | 422.82M | -637.33M | 2.28 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
노바백스 Stock (NVAX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-24 | 재개 | Cantor Fitzgerald | Overweight |
| 2025-08-28 | 재개 | H.C. Wainwright | Buy |
| 2025-08-20 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2025-06-17 | 개시 | Citigroup | Sell |
| 2025-02-28 | 개시 | BTIG Research | Buy |
| 2024-07-30 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2024-05-10 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2024-05-10 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2023-08-09 | 업그레이드 | B. Riley Securities | Neutral → Buy |
| 2023-04-20 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2023-03-01 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2023-01-09 | 재확인 | B. Riley Securities | Buy |
| 2022-12-30 | 재확인 | H.C. Wainwright | Buy |
| 2022-12-02 | 개시 | Jefferies | Hold |
| 2022-09-22 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2022-05-20 | 개시 | BofA Securities | Underperform |
| 2022-02-23 | 재확인 | B. Riley Securities | Buy |
| 2022-02-22 | 재개 | Jefferies | Buy |
| 2022-01-21 | 개시 | Cowen | Outperform |
| 2021-05-12 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-12-14 | 개시 | Jefferies | Buy |
| 2020-08-06 | 재확인 | H.C. Wainwright | Buy |
| 2020-08-05 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-08-05 | 다운그레이드 | Ladenburg Thalmann | Neutral → Sell |
| 2020-07-16 | 재확인 | H.C. Wainwright | Buy |
| 2020-07-08 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2020-06-29 | 재확인 | B. Riley FBR | Buy |
| 2020-06-29 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-05 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2020-05-28 | 재확인 | B. Riley FBR | Buy |
| 2020-05-12 | 재확인 | H.C. Wainwright | Buy |
| 2020-04-30 | 재확인 | H.C. Wainwright | Buy |
| 2019-11-27 | 재개 | B. Riley FBR | Buy |
| 2019-08-14 | 재확인 | H.C. Wainwright | Buy |
| 2019-02-28 | 다운그레이드 | Piper Jaffray | Overweight → Underweight |
| 2018-12-18 | 개시 | Ladenburg Thalmann | Buy |
| 2018-12-11 | 개시 | Oppenheimer | Outperform |
| 2018-11-26 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2018-09-21 | 업그레이드 | JP Morgan | Underweight → Overweight |
| 2018-03-29 | 업그레이드 | Seaport Global Securities | Neutral → Buy |
모두보기
노바백스 주식(NVAX)의 최신 뉴스
CDC study finds COVID shot significantly reduced ER visits for children - Seeking Alpha
Why I wouldn't touch Novavax with a 10-foot pole - MSN
Why I Wouldn't Touch Novavax With a 10-Foot Pole - Nasdaq
NVAX Stock Today: Can Novavax Turn Regulatory Turmoil and Activist Pressure into a Comeback? - ts2.tech
Novavax Inc. Stock Underperforms Tuesday When Compared To Competitors - 富途牛牛
Novavax, Inc. (NASDAQ:NVAX) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock - Yahoo Finance
Lobbying Update: $30,000 of NOVAVAX lobbying was just disclosed - Quiver Quantitative
Novavax, Inc. (NVAX): A Bull Case Theory - Finviz
Novavax, Inc. (NVAX): A bull case theory - MSN
Will Novavax Inc. (NVV1) stock deliver stable dividendsMarket Movement Recap & Verified Technical Signals - Newser
How Novavax Inc. (NVV1) stock benefits from digital adoptionJuly 2025 Action & Weekly Breakout Watchlists - Newser
How Novavax Inc. (NVV1) stock gains from tech spendingRisk Management & Weekly Stock Performance Updates - Newser
Novavax (NVAX): Exploring Valuation After Prolonged Share Price Weakness - Yahoo Finance
Why pension funds invest in Novavax Inc. (NVV1) stockEarnings Summary Report & Long-Term Growth Plans - Newser
Discipline and Rules-Based Execution in NVAX Response - news.stocktradersdaily.com
Bank of America Securities Sticks to Their Sell Rating for Novavax (NVAX) - The Globe and Mail
Why Novavax Inc. stock could see breakout soonWeekly Trend Summary & AI Forecasted Stock Moves - Newser
How Novavax Inc. (NVV1) stock reacts to Fed tighteningInsider Selling & Verified Swing Trading Watchlist - Newser
Vaccine developers’ stocks dip after Prasad memo becomes public - BioCentury
Moderna, Novavax Shares Fall on News FDA Plans to Tighten Vaccine Approvals - The Wall Street Journal
Moderna and Novavax Stocks Drop as FDA Outlines Stricter Vaccine Approvals - Barron's
Moderna and Novavax Stocks Drop as FDA Proposes Stricter Vaccine Approvals - Barron's
Moderna Falls as FDA Vows to Impose New Vaccine Requirements - Bloomberg.com
Cash from financing activities of Novavax, Inc. – SIX:NVAX.USD - TradingView
Intech Investment Management LLC Sells 58,151 Shares of Novavax, Inc. $NVAX - MarketBeat
What drives Global Ship Lease Inc stock priceReal-Time Stock Alerts & Capital Efficiency Improvement - earlytimes.in
Will Novavax Inc. stock outperform international peersJuly 2025 Trends & Technical Pattern Recognition Alerts - BỘ NỘI VỤ
Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch
Should You Follow Insider Buying Trends for India Steel Works LimitedWeekly Market Snapshot & Free Stock Index Interpretations - earlytimes.in
What drives Novavax Inc stock priceMarket Profile Overview & Free Explosive Return Secrets - earlytimes.in
Can Ganga Papers India Limited Maintain Shareholder Returns via BuybacksEmerging Market Stocks & Superior Trading Portfolio - earlytimes.in
Novavax Inc. Stock Climbs 3.9%, Outperforms Peers - 富途牛牛
Novavax Shifts From COVID Sales to R&D Focus While Updating 2025 Forecast - MSN
Shah Capital continues push for potential Novavax sale - Alternatives Watch
Milestones Over Sales: The Sanofi Partnership Now Drives Novavax’s Outlook (NVAX) - Seeking Alpha
January 2026 Options Now Available For Novavax (NVAX) - Nasdaq
Novavax’s R&D Shift and Sanofi Partnership Could Be a Game Changer for NVAX - Yahoo Finance
What Recent Partnership Efforts Mean for the Value of Novavax in 2025 - Yahoo Finance
Novavax slips as Citi launches with Sell rating on pipeline concerns - MSN
Is Trending Stock Novavax, Inc. (NVAX) a Buy Now? - sharewise.com
Novavax Inc. stock rises Monday, still underperforms market - MarketWatch
9 Oversold Biotech Stocks to Invest In - Insider Monkey
Novavax rises after a seven-day slide - MSN
Behavioral Patterns of NVAX and Institutional Flows - news.stocktradersdaily.com
Novavax, UniFirst, and More Stocks See Action From Activist Investors - Barron's
Interesting NVAX Put And Call Options For July 2026 - Nasdaq
How rising interest rates impact Novavax Inc. stockWeekly Risk Report & Reliable Intraday Trade Alerts - newser.com
Is Novavax Inc. stock undervalued vs historical averagesJuly 2025 Reactions & Weekly Hot Stock Watchlists - newser.com
Will Novavax Inc. (NVV1) stock hit Wall Street targets2025 Analyst Calls & Low Volatility Stock Suggestions - newser.com
Why Novavax Inc. stock appeals to dividend seekers2025 Fundamental Recap & AI Powered Trade Plan Recommendations - newser.com
노바백스 (NVAX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
노바백스 주식 (NVAX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| MCGLYNN MARGARET G | Director |
Jun 12 '25 |
Option Exercise |
0.00 |
10,420 |
0 |
25,588 |
| Alton Gregg H | Director |
Jun 12 '25 |
Option Exercise |
0.00 |
10,420 |
0 |
28,805 |
| King Rachel K. | Director |
Jun 12 '25 |
Option Exercise |
0.00 |
10,420 |
0 |
25,190 |
| Rodgers Richard J | Director |
Jun 12 '25 |
Option Exercise |
0.00 |
10,420 |
0 |
24,690 |
| MOTT DAVID M | Director |
Jun 12 '25 |
Option Exercise |
0.00 |
10,420 |
0 |
60,890 |
| DOUGLAS RICHARD | Director |
Jun 12 '25 |
Option Exercise |
0.00 |
10,420 |
0 |
54,340 |
1.08%
0.91%
자본화:
|
볼륨(24시간):